Europe Respiratory Syncytial Virus Diagnostics Market Size & Outlook
Europe respiratory syncytial virus diagnostics market, 2018-2030 (US$M)
Related Markets
Europe respiratory syncytial virus diagnostics market highlights
- The Europe respiratory syncytial virus diagnostics market generated a revenue of USD 1,972.5 million in 2024.
- The market is expected to grow at a CAGR of 5.2% from 2025 to 2030.
- In terms of segment, chromatographic immunoassay was the largest revenue generating product in 2024.
- Gel Microdroplets is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 1,972.5 million |
| Market revenue in 2030 | USD 2,638.7 million |
| Growth rate | 5.2% (CAGR from 2025 to 2030) |
| Largest segment | Chromatographic immunoassay |
| Fastest growing segment | Gel Microdroplets |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Direct Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test (RADTs), Molecular Diagnostics, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, Chromatographic Immunoassay |
| Key market players worldwide | Becton Dickinson & Co, Novartis AG ADR, Abbott Laboratories, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Roche Holding AG ADR, BioMerieux SA, Diasorin SpA, Merck KGaA, Avacta Group PLC, Siemens Healthineers AG ADR, Quest Diagnostics Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 31.4% of the global respiratory syncytial virus diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,957.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Respiratory Syncytial Virus Diagnostics Market Scope
Respiratory Syncytial Virus Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe respiratory syncytial virus diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to respiratory syncytial virus diagnostics market will help companies and investors design strategic landscapes.
Chromatographic immunoassay was the largest segment with a revenue share of 28.61% in 2024. Horizon Databook has segmented the Europe respiratory syncytial virus diagnostics market based on direct fluorescent antibody (dfa) method, rapid antigen diagnostic test (radts), molecular diagnostics, diagnostic imaging, gel microdroplets, flow cytometry, chromatographic immunoassay covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for a significant share of the market. This can be attributed to the rising awareness of RSV’s impact on vulnerable populations, such as infants and the elderly. Increasing adoption of rapid, cost-effective diagnostic solutions in hospitals and outpatient settings is driving demand.
Reasons to subscribe to Europe respiratory syncytial virus diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe respiratory syncytial virus diagnostics market databook
-
Our clientele includes a mix of respiratory syncytial virus diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe respiratory syncytial virus diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe respiratory syncytial virus diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe respiratory syncytial virus diagnostics market size, by country, 2018-2030 (US$M)
Europe Respiratory Syncytial Virus Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
